Clinical Trial Update: Study of MAR001 in Adults With Metabolic Dysfunction [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial of MAR001 in adults with metabolic dysfunction focusing on hypertriglyceridemia has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• MAR001

Snippet

Sponsor: Marea Therapeutics | Conditions: Hypertriglyceridemia | Phase 1, Phase 2 | Status: COMPLETED